{"entity":{"type":"insider","cik":"0001826036","url":"/insider/0001826036","json_url":"/insider/0001826036.json","name":"Ginocchio Paul","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":9,"first":"2021-05-21","last":"2024-05-17","span_basis":"filed_date"},"name_variants":[{"name":"Ginocchio Paul","source":"filing","n_filings":9,"first_seen":"2021-05-21","last_seen":"2024-05-17"}],"transactions":[{"id":2037906,"accession":"0001213900-24-044880","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-044880","line_url":"/filing/0001213900-24-044880#line-2","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826036","owner_name":"Ginocchio Paul","owner_display_name":"Ginocchio Paul","owner_url":"/insider/0001826036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2354.0,"shares_display":"2,354","price_per_share":1.19,"price_display":"1.19","price_state":"stated","total_value":2801.26,"total_display":"2,801.26","total_whole":"2,801","shares_owned_after":131896.0,"shares_owned_after_display":"131,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-17","scope":"insider"},{"id":8631501,"accession":"0001213900-23-089962","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-089962","line_url":"/filing/0001213900-23-089962#line-1","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826036","owner_name":"Ginocchio Paul","owner_display_name":"Ginocchio Paul","owner_url":"/insider/0001826036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.85,"price_display":"4.85","price_state":"stated","total_value":48500.0,"total_display":"48,500.00","total_whole":"48,500","shares_owned_after":128000.0,"shares_owned_after_display":"128,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-22","filed_date":"2023-11-27","scope":"insider"},{"id":6279765,"accession":"0001213900-22-080096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-22-080096","line_url":"/filing/0001213900-22-080096#line-1","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826036","owner_name":"Ginocchio Paul","owner_display_name":"Ginocchio Paul","owner_url":"/insider/0001826036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18000.0,"shares_display":"18,000","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":21600.0,"total_display":"21,600.00","total_whole":"21,600","shares_owned_after":118000.0,"shares_owned_after_display":"118,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-13","filed_date":"2022-12-15","scope":"insider"},{"id":6827415,"accession":"0001213900-22-030198","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-22-030198","line_url":"/filing/0001213900-22-030198#line-2","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826036","owner_name":"Ginocchio Paul","owner_display_name":"Ginocchio Paul","owner_url":"/insider/0001826036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.04,"price_display":"2.04","price_state":"stated","total_value":4080.0,"total_display":"4,080.00","total_whole":"4,080","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-05-27","scope":"insider"},{"id":6827409,"accession":"0001213900-22-030198","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-22-030198","line_url":"/filing/0001213900-22-030198#line-1","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826036","owner_name":"Ginocchio Paul","owner_display_name":"Ginocchio Paul","owner_url":"/insider/0001826036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000.0,"shares_display":"16,000","price_per_share":1.99,"price_display":"1.99","price_state":"stated","total_value":31840.0,"total_display":"31,840.00","total_whole":"31,840","shares_owned_after":98000.0,"shares_owned_after_display":"98,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-27","scope":"insider"},{"id":4850361,"accession":"0001213900-21-061681","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-061681","line_url":"/filing/0001213900-21-061681#line-1","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826036","owner_name":"Ginocchio Paul","owner_display_name":"Ginocchio Paul","owner_url":"/insider/0001826036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14000.0,"shares_display":"14,000","price_per_share":2.96,"price_display":"2.96","price_state":"stated","total_value":41440.0,"total_display":"41,440.00","total_whole":"41,440","shares_owned_after":82000.0,"shares_owned_after_display":"82,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-23","scope":"insider"},{"id":4345480,"accession":"0001213900-21-055923","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-055923","line_url":"/filing/0001213900-21-055923#line-1","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826036","owner_name":"Ginocchio Paul","owner_display_name":"Ginocchio Paul","owner_url":"/insider/0001826036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34000.0,"shares_display":"34,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":136000.0,"total_display":"136,000.00","total_whole":"136,000","shares_owned_after":68000.0,"shares_owned_after_display":"68,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-28","filed_date":"2021-11-01","scope":"insider"},{"id":4679803,"accession":"0001213900-21-031673","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-031673","line_url":"/filing/0001213900-21-031673#line-2","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826036","owner_name":"Ginocchio Paul","owner_display_name":"Ginocchio Paul","owner_url":"/insider/0001826036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2044.0,"shares_display":"2,044","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":11242.0,"total_display":"11,242.00","total_whole":"11,242","shares_owned_after":34000.0,"shares_owned_after_display":"34,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-08","filed_date":"2021-06-09","scope":"insider"},{"id":4679798,"accession":"0001213900-21-031673","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-031673","line_url":"/filing/0001213900-21-031673#line-1","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826036","owner_name":"Ginocchio Paul","owner_display_name":"Ginocchio Paul","owner_url":"/insider/0001826036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":31956.0,"shares_owned_after_display":"31,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider"},{"id":4162829,"accession":"0000899243-21-020924","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-020924","line_url":"/filing/0000899243-21-020924#line-1","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826036","owner_name":"Ginocchio Paul","owner_display_name":"Ginocchio Paul","owner_url":"/insider/0001826036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9356.0,"shares_display":"9,356","price_per_share":4.56,"price_display":"4.56","price_state":"stated","total_value":42663.36,"total_display":"42,663.36","total_whole":"42,663","shares_owned_after":21956.0,"shares_owned_after_display":"21,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-25","filed_date":"2021-05-27","scope":"insider"},{"id":5392148,"accession":"0000899243-21-020403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-020403","line_url":"/filing/0000899243-21-020403#line-1","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826036","owner_name":"Ginocchio Paul","owner_display_name":"Ginocchio Paul","owner_url":"/insider/0001826036","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12600.0,"shares_display":"12,600","price_per_share":3.96,"price_display":"3.96","price_state":"stated","total_value":49896.0,"total_display":"49,896.00","total_whole":"49,896","shares_owned_after":12600.0,"shares_owned_after_display":"12,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-19","filed_date":"2021-05-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001769804","name":"Augmedix, Inc.","url":"/issuer/0001769804","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":9,"first_seen":"2021-05-21","last_seen":"2024-05-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001826036","retrieved_at":"2026-08-25T01:17:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}